These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10712030)

  • 21. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
    Hoffmann H
    Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trials referral resource. Non-small-cell lung cancer.
    Cheson BD; Phillips PH; Feigal EG
    Oncology (Williston Park); 1994 Feb; 8(2):56, 61, 65. PubMed ID: 8167088
    [No Abstract]   [Full Text] [Related]  

  • 23. [Recommendations on the therapy of bronchial carcinoma].
    Thomas M; Baumann M; Deppermann M; Freitag L; Gatzemeier U; Huber R; Passlick B; Serke M; Ukena D
    Pneumologie; 2002 Feb; 56(2):113-31. PubMed ID: 11842350
    [No Abstract]   [Full Text] [Related]  

  • 24. A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer.
    Huncharek M; McGarry R
    Oncologist; 2004; 9(6):665-72. PubMed ID: 15561810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The difficult choice: when not to treat. Advanced lung cancer].
    Migliorino MR
    Suppl Tumori; 2004; 3(4):S91-2. PubMed ID: 15206225
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials.
    Hotta K; Matsuo K; Ueoka H; Kiura K; Tabata M; Tanimoto M
    J Clin Oncol; 2004 Oct; 22(19):3860-7. PubMed ID: 15326194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
    Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NCCN Non-Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network.
    Ettinger DS; Cox JD; Ginsberg RJ; Komaki R; Kris MG; Livingston RB; Sugarbaker DJ
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):81-111. PubMed ID: 8953597
    [No Abstract]   [Full Text] [Related]  

  • 29. Meta-analyses of clinical trials in patients with non-small cell lung cancer. Minireview.
    Kovac V; Smrdel U
    Neoplasma; 2004; 51(5):334-40. PubMed ID: 15640936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which patients with stage III non-small cell lung cancer should undergo surgical resection?
    Patel V; Shrager JB
    Oncologist; 2005 May; 10(5):335-44. PubMed ID: 15851792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodality therapy for stage III non-small-cell lung cancer.
    Farray D; Mirkovic N; Albain KS
    J Clin Oncol; 2005 May; 23(14):3257-69. PubMed ID: 15886313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant versus adjuvant therapy for resectable non-small-cell lung cancer.
    Belani CP
    Clin Lung Cancer; 2004 Jul; 6(1):8. PubMed ID: 15310410
    [No Abstract]   [Full Text] [Related]  

  • 33. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
    Thomas M; Hoffknecht P; Droege C; Baisch A; Reinmuth N; Kreuter M; Lange T; Berdel WE
    Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lung cancer--epidemiology, prognosis and therapy].
    Martini B
    Med Monatsschr Pharm; 2006 Jun; 29(6):217-21. PubMed ID: 16792198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy.
    Forquer JA; Fakiris AJ; McGarry RC; Cheung MK; Watson C; Harkenrider M; Henderson MA; Lo SS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1443-53. PubMed ID: 19828006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined modality treatment of lung cancer (NSCLC and SCLC).
    Delbaldo C; Le Péchoux C; Le Chevalier T
    Cancer Chemother Biol Response Modif; 2002; 20():677-95. PubMed ID: 12703230
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined modality therapy for non-small cell lung carcinoma.
    Machtay M; Glatstein E
    Cancer J; 2002; 8 Suppl 1():S55-67. PubMed ID: 12075703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus on medical treatment of non-small cell lung cancer.
    ; ;
    Lung Cancer; 2002 Dec; 38 Suppl 3():S3-7. PubMed ID: 12468137
    [No Abstract]   [Full Text] [Related]  

  • 40. Switch maintenance versus second-line treatment in non-small cell lung cancer.
    Rossi A; Torri V; Gridelli C
    J Thorac Oncol; 2011 Jul; 6(7):1298. PubMed ID: 21847047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.